ARCEDI BIOTECH ApS: Financial statements 2015
CVR: 25577922
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
ARCEDI BIOTECH ApS (CVR 25577922) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -2,343,000 and a net result of DKK -2,269,000 compared with DKK -1,183,000 the year before. Equity in the 2015 report amounted to DKK -3,372,000.
- Gross Profit
- DKK -2,343,000
- Profit/Loss
- DKK -2,269,000
- Equity
- DKK -3,372,000
- Total Assets
- DKK 16,553,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -2.3 mio. | -2.3 mio. | -3.4 mio. | - |
| 2014 | - | -781 t. | -1.2 mio. | -1.1 mio. | - |
Official annual report
How creditworthy is ARCEDI BIOTECH ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of May 31, 2015, SoLoCa ApS is registered as an owner of ARCEDI BIOTECH ApS with an ownership share of 10%.
ARCEDI BIOTECH ApS has published its annual report for 2014. Gross profit came to DKK -781,000, and the net result was DKK -1,183,000.
About ARCEDI BIOTECH ApS
ARCEDI BIOTECH ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2013. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Mads Tang Dalsgaard and John Riis Mortensen. The board consists of Tonni Bülow-Nielsen (chair), Claus Bagger-Sørensen, Hans-Henrik Horsted Eriksen and Søren Birn. The company's owners include BAKODO ApS, BAGGER-SØRENSEN & CO. A/S and SoLoCa ApS. The company has 15 employees (2018). In 2025, the company reported a gross profit of DKK -11,636,000 and a net result of DKK -45,882,000 compared with DKK -41,961,000 the year before. Equity in the 2025 report amounted to DKK -173,640,000.